"The evidence from the clinical trial is compelling. It showed that people taking semaglutide alongside their existing heart medicines were significantly less likely to have another heart attack or stroke."
"Today's decision gives thousands of people in that situation an extra layer of protection, on top of the medicines they are already taking."
Wegovy, a weight-loss injection, will be available for free on the NHS to over a million people in England at risk of heart attacks and strokes. NICE recommends it for those with serious circulation issues and who are overweight. Clinical trials indicate Wegovy can reduce the risk of heart and circulation problems, showing benefits early in trials. Patients can self-administer the drug at home, providing an additional layer of protection alongside existing heart medications and a healthy diet.
Read at www.bbc.com
Unable to calculate read time
Collection
[
|
...
]